Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Microsoft
MSFT
|
+$667M |
| 3 |
Spotify
SPOT
|
+$528M |
| 4 |
iShares Bitcoin Trust
IBIT
|
+$438M |
| 5 |
Eli Lilly
LLY
|
+$412M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.59B |
| 2 |
Amazon
AMZN
|
+$1.45B |
| 3 |
Merck
MRK
|
+$925M |
| 4 |
Broadcom
AVGO
|
+$765M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$672M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.59% |
| 2 | Healthcare | 7.29% |
| 3 | Financials | 7.2% |
| 4 | Industrials | 6.32% |
| 5 | Consumer Discretionary | 4.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
PUT
L3Harris
LHX
$51.7B
| $2.21M | ﹤0.01% |
+9,300
| New | +$2.15M |
|
3502
NCR Atleos
NATL
$3.44B
| $2.21M | ﹤0.01% |
77,490
-238,439
| -75% | -$6.94M |
|
3503
CALL
Tenet Healthcare
THC
$20.1B
| $2.21M | ﹤0.01% |
13,300
-5,700
| -30% | -$862K |
|
3504
PUT
Murphy Oil
MUR
$5.55B
| $2.21M | ﹤0.01% |
65,400
| – | – |
|
3505
Lexicon Pharmaceuticals
LXRX
$1.03B
| $2.2M | ﹤0.01% |
1,398,876
+801,555
| +134% | +$1.43M |
|
3506
CALL
Kinross Gold
KGC
$27.8B
| $2.2M | ﹤0.01% |
+234,600
| New | +$2.11M |
|
3507
iShares MSCI USA Value Factor ETF
VLUE
$9.21B
| $2.19M | ﹤0.01% |
20,110
+1,236
| +7% | +$130K |
|
3508
Encore Capital Group
ECPG
$2.06B
| $2.19M | ﹤0.01% |
46,370
-33,800
| -42% | -$1.6M |
|
3509
Invesco S&P 500 Equal Weight ETF
RSP
$98.1B
| $2.19M | ﹤0.01% |
12,231
-131,565
| -91% | -$22.5M |
|
|
IGMS
3510
DELISTED
IGM Biosciences
IGMS
| $2.19M | ﹤0.01% |
132,342
-258,871
| -66% | -$2.84M |
|
3511
CALL
Scorpio Tankers
STNG
$3.89B
| $2.19M | ﹤0.01% |
30,700
-1,700
| -5% | -$124K |
|
3512
CALL
Omnicell
OMCL
$1.71B
| $2.19M | ﹤0.01% |
50,200
+40,200
| +402% | +$1.51M |
|
3513
CALL
Henry Schein
HSIC
$9.85B
| $2.19M | ﹤0.01% |
+30,000
| New | +$2.08M |
|
3514
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
| $2.18M | ﹤0.01% |
+64,753
| New | +$2.15M |
|
3515
XBiotech
XBIT
$68M
| $2.17M | ﹤0.01% |
281,019
-80,642
| -22% | -$530K |
|
|
GTM
3516
CALL
ZoomInfo Technologies
GTM
$1.05B
| $2.17M | ﹤0.01% |
210,000
+96,500
| +85% | +$1.01M |
|
3517
Horizon Technology Finance
HRZN
$308M
| $2.17M | ﹤0.01% |
+203,424
| New | +$2.33M |
|
3518
PUT
BHP
BHP
$212B
| $2.16M | ﹤0.01% |
34,700
+21,500
| +163% | +$1.19M |
|
3519
PUT
Neurocrine Biosciences
NBIX
$16.7B
| $2.15M | ﹤0.01% |
+18,700
| New | +$2.56M |
|
3520
PUT
CBRE Group
CBRE
$43B
| $2.15M | ﹤0.01% |
17,300
+7,800
| +82% | +$850K |
|
3521
CION Investment
CION
$311M
| $2.15M | ﹤0.01% |
180,892
-40,990
| -18% | -$495K |
|
3522
Vanguard Morningstar Value ETF
VTV
$189B
| $2.15M | ﹤0.01% |
12,322
-31,036
| -72% | -$5.2M |
|
3523
FIGS
FIGS
$1.82B
| $2.15M | ﹤0.01% |
313,747
-309,789
| -50% | -$1.81M |
|
3524
FirstService
FSV
$6.61B
| $2.14M | ﹤0.01% |
11,747
-197,550
| -94% | -$34M |
|
|
AKRO
3525
DELISTED
Akero Therapeutics
AKRO
| $2.14M | ﹤0.01% |
74,628
-94,963
| -56% | -$2.48M |
|
Similar funds
Millennium Management's Q3 2024 Portfolio in Review
As of Q3 2024, Millennium Management held 6,698 positions worth $211B, down 2.3% from $216B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Millennium Management withdrew a net $20.6B in Q3 2024, closing 667 positions and reducing 2,445 holdings. Its most notable exit was WestRock Company, an estimated $161M position sold in full.
By sector, the portfolio is most concentrated in Technology at 8.6% of assets, down from 10% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Millennium Management opened a new position in Smurfit Westrock worth $94.1M.
- Millennium Management's largest Q3 2024 buy was Smurfit Westrock: 1,904,931 shares worth $94.1M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $1.38B increase.
- Millennium Management's biggest Q3 2024 reduction was Apple, cutting an estimated $2.59B.
- Millennium Management fully exited WestRock Company in Q3 2024, selling an estimated $161M.
- Millennium Management's ten largest holdings make up 17% of its $211B portfolio in Q3 2024.
- Millennium Management opened 898 new positions and closed 667 in Q3 2024.
- Millennium Management's portfolio value fell 2.3% quarter-over-quarter to $211B.
Based on Millennium Management's 13F filing for Q3 2024, filed 14 Nov 2024.